Quantum technologies promise secure communication networks, powerful forms of computing and new sensing tools. One of the major challenges, however, is that different quantum systems often operate at ...
MusicRadar on MSN
Bitwig Studio 6.1 launches with "radically updated" Sampler device
The German developer promises its overhauled Sampler device will "invite you to sample in ways that weren't possible before" ...
As superconducting quantum processors reach the thousand-qubit regime, increasing qubit count makes detuning more challenging ...
A new control protocol boosts fidelity in systems using Rydberg qubits, dynamically suppressing excitation while leveraging ...
ENIGMA-TRS 1 is a Phase 3 international, one-year, randomized, double-blind, placebo-controlled study in 600+ patients; 12-week study results ...
Pyrotech Therapeutics ("Pyrotech" or the "Company"), a clinical-stage biopharmaceutical company pioneering innate immune modulation and pyroptosis-targeted therapies, announced that the first healthy ...
BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that the last ...
A TWO-PHASE randomised clinical trial has shown that low-dose hydrocortisone acutely sharpens verbal learning, memory and ...
A two-dimensional gas chromatography-time-of-flight mass spectrometry method detects legacy pesticides and PCBs below guideline levels.
As innovation emerges from every corner of the ecosystem, collaboration is no longer optional. It is essential. At GSK, this ...
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that has completed the last on-treatment visit in its Phase 2 ADDRESS-LC clinical trial evaluating bezisterim in adults with Long COVID, with topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results